1.
Product
Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research
Methodology
2.1.
Objective of
the Study
2.2.
Baseline
Methodology
2.3.
Key Industry
Partners
2.4.
Major
Association and Secondary Sources
2.5.
Forecasting
Methodology
2.6.
Data
Triangulation & Validation
2.7.
Assumptions
and Limitations
3.
Executive
Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Breast Cancer
Diagnostics Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Type (Imaging, Biopsy, Genomic
Tests, Blood Tests, Others)
5.2.2.
By Product (Platform-based Products (Next-generation
Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging,
Biopsy))
5.2.3.
By Application (Screening, Diagnostic and Predictive, Prognostic,
Research, Others)
5.2.4.
By End-use (Hospitals & Clinics, Diagnostic Centers
and Medical Laboratories, Others)
5.2.5. By
Region
5.2.6.
By Company (2023)
5.3.
Product Market Map
5.3.1.
By Type
5.3.2.
By Product
5.3.3.
By Application
5.3.4.
By End-use
5.3.5.
By Region
6. North America Breast
Cancer Diagnostics Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Type (Imaging, Biopsy, Genomic Tests, Blood Tests,
Others)
6.2.2.
By Product (Platform-based Products (Next-generation
Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging,
Biopsy))
6.2.3.
By Application (Screening, Diagnostic and Predictive, Prognostic,
Research, Others)
6.2.4.
By End-use (Hospitals & Clinics, Diagnostic Centers and Medical
Laboratories, Others)
6.2.5.
By Country
6.3.
North America: Country Analysis
6.3.1.
United States Breast Cancer Diagnostics Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Product
6.3.1.2.3.
By Application
6.3.1.2.4.
By End-use
6.3.2.
Canada Breast Cancer Diagnostics Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Product
6.3.2.2.3.
By Application
6.3.2.2.4.
By End-use
6.3.3.
Mexico Breast Cancer Diagnostics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Product
6.3.3.2.3.
By Application
6.3.3.2.4.
By End-use
7. Europe Breast Cancer
Diagnostics Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Type (Imaging, Biopsy, Genomic Tests, Blood Tests,
Others)
7.2.2.
By Product (Platform-based Products (Next-generation
Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging,
Biopsy))
7.2.3.
By Application (Screening, Diagnostic and Predictive, Prognostic,
Research, Others)
7.2.4.
By End-use (Hospitals & Clinics, Diagnostic Centers and Medical
Laboratories, Others)
7.2.5.
By Country
7.3.
Europe: Country Analysis
7.3.1.
Germany Breast Cancer Diagnostics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Product
7.3.1.2.3.
By Application
7.3.1.2.4.
By End-use
7.3.2.
United Kingdom Breast Cancer Diagnostics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Product
7.3.2.2.3.
By Application
7.3.2.2.4.
By End-use
7.3.3.
France Breast Cancer Diagnostics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Product
7.3.3.2.3.
By Application
7.3.3.2.4.
By End-use
7.3.4.
Italy Breast Cancer Diagnostics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Product
7.3.4.2.3.
By Application
7.3.4.2.4.
By End-use
7.3.5.
Spain Breast Cancer Diagnostics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Product
7.3.5.2.3.
By Application
7.3.5.2.4.
By End-use
8. Asia-Pacific Breast
Cancer Diagnostics Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Type (Imaging, Biopsy, Genomic Tests, Blood Tests,
Others)
8.2.2.
By Product (Platform-based Products (Next-generation
Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging,
Biopsy))
8.2.3.
By Application (Screening, Diagnostic and Predictive, Prognostic,
Research, Others)
8.2.4.
By End-use (Hospitals & Clinics, Diagnostic Centers and Medical
Laboratories, Others)
8.2.5.
By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1.
China Breast Cancer Diagnostics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Product
8.3.1.2.3.
By Application
8.3.1.2.4.
By End-use
8.3.2.
Japan Breast Cancer Diagnostics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Product
8.3.2.2.3.
By Application
8.3.2.2.4.
By End-use
8.3.3.
India Breast Cancer Diagnostics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Product
8.3.3.2.3.
By Application
8.3.3.2.4.
By End-use
8.3.4.
Australia Breast Cancer Diagnostics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Product
8.3.4.2.3.
By Application
8.3.4.2.4.
By End-use
8.3.5.
South Korea Breast Cancer Diagnostics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Product
8.3.5.2.3.
By Application
8.3.5.2.4.
By End-use
9. South America Breast
Cancer Diagnostics Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Type (Imaging, Biopsy, Genomic Tests, Blood Tests,
Others)
9.2.2.
By Product (Platform-based Products (Next-generation
Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging,
Biopsy))
9.2.3.
By Application (Screening, Diagnostic and Predictive, Prognostic,
Research, Others)
9.2.4.
By End-use (Hospitals & Clinics, Diagnostic Centers and Medical
Laboratories, Others)
9.2.5.
By Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Breast Cancer Diagnostics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Product
9.3.1.2.3.
By Application
9.3.1.2.4.
By End-use
9.3.2.
Argentina Breast Cancer Diagnostics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Product
9.3.2.2.3.
By Application
9.3.2.2.4.
By End-use
9.3.3.
Colombia Breast Cancer Diagnostics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Product
9.3.3.2.3.
By Application
9.3.3.2.4.
By End-use
10. Middle East and
Africa Breast Cancer Diagnostics Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Type (Imaging, Biopsy, Genomic Tests, Blood Tests,
Others)
10.2.2.
By Product (Platform-based Products (Next-generation
Sequencing, Microarrays, PCR, Others), Instrument-based Products (Imaging,
Biopsy))
10.2.3.
By Application (Screening, Diagnostic and Predictive, Prognostic,
Research, Others)
10.2.4.
By End-use (Hospitals & Clinics, Diagnostic Centers and Medical
Laboratories, Others)
10.2.5.
By Country
10.3.
MEA: Country Analysis
10.3.1.
South Africa Breast Cancer Diagnostics Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Product
10.3.1.2.3.
By Application
10.3.1.2.4.
By End-use
10.3.2.
Saudi Arabia Breast Cancer Diagnostics Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Product
10.3.2.2.3.
By Application
10.3.2.2.4.
By End-use
10.3.3.
UAE Breast Cancer Diagnostics Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Product
10.3.3.2.3.
By Application
10.3.3.2.4.
By End-use
10.3.4.
Kuwait Breast Cancer Diagnostics Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Type
10.3.4.2.2.
By Product
10.3.4.2.3.
By Application
10.3.4.2.4.
By End-use
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13. Porter’s
Five Forces Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Products
14.
Competitive Landscape
14.1. Hologic Inc
14.1.1. Business Overview
14.1.2. Product Offerings
14.1.3. Recent Developments
14.1.4. Financials (As Reported)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Exact Sciences Corporation
14.3. Becton, Dickinson & Co
14.4. Danaher Corp
14.5. Koninklijke Philips NV
14.6. QIAGEN NV
14.7. Thermo Fisher Scientific Inc
14.8. Myriad Genetics Inc
14.9. Argon Medical Devices
14.10. F
Hoffmann-La Roche Ltd
15. Strategic
Recommendations
16.
About Us & Disclaimer